Loading clinical trials...
Loading clinical trials...
Prospective Neurobehavioral Evaluation in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost
Conditions
Interventions
A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
Locations
1
Taiwan
Chang Gung Memorial Hospital
Taoyuan District, Taiwan
Start Date
March 1, 2019
Primary Completion Date
February 18, 2029
Completion Date
February 18, 2029
Last Updated
May 1, 2023
NCT06931652
NCT05036564
NCT04464200
NCT05293990
NCT04073147
NCT05021770
Lead Sponsor
Chang Gung Memorial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions